AI assistant
Amoéba — Regulatory Filings 2017
May 15, 2017
1107_rns_2017-05-15_01fbc1ce-bfc0-4c41-94af-81352b7de073.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
PRESS RELEASE
NOVOCHEM signs a distribution agreement for the Benelux First Letter of Intent leading to a contract in Europe
Lyon, Houten, May 15 th 2017 - AMOEBA (FR0011051598 - AMEBA), producer of a biological biocide capable of eliminating bacterial risk in water, announced today that it has signed a distribution agreement for its BIOMEBA product with NOVOCHEM Water Treatment. This agreement is pending marketing authorization (MA) in the Netherlands, Belgium and Luxembourg.
The collaboration between NOVOCHEM and AMOEBA started in 2015 with the signature of a Letter of Intention (LOI).
In 2016, a first industrial field test was deployed in the Netherlands with a client of NOVOCHEM in the tertiary sector. This successful test, still running after ten months, has confirmed the effectiveness of BIOMEBA. As a result, NOVOCHEM will start a second industrial field test in May in the heavy industry sector.
With the signature of this distribution agreement, prior marketing authorization, NOVOCHEM demonstrates its trust in the pursuit of the regulatory process and in the effectiveness of BIOMEBA. In addition, NOVOCHEM is committed to assist AMOEBA to defend his regulatory dossier in front of the European bodies.
« The industrial field tests conducted have proven BIOMEBA product's effectiveness. We believe in this innovative technology and today, we want to be able to offer this biological alternative for chemical biocides to our industrials clients. » says Robin WITTE, Director of NOVOCHEM Water Treatment.
« I would like to thank NOVOCHEM for the quality of their teams and their professionalism which are key elements of this success. As a result, we are very proud of this first transformation of a LOI into a contractual agreement. This signature demonstrates a true commitment between AMOEBA and NOVOCHEM for the commercialization of BIOMEBA in Benelux. » states Fabrice PLASSON, President of AMOEBA's Board of Directors.
About NOVOCHEM Water Treatment:
Performance and quality are the main values for NOVOCHEM Group, both for our products and for the environment. Our pro-active approach with high-performance products like NovoTraqua has resulted in ecologically and socially responsible solutions. This is why NOVOCHEM can offer a wide range of high-performance, low-toxicity products, which has made NOVOCHEM one of the leading water treatment companies in the Benelux. For more information: www.novochemgroup.com.
About AMOEBA:
AMOEBA develops a biological biocide capable of eliminating waterborne bacterial risk (legionella, pseudomonas, listeria, etc.). This entirely natural solution is presented as an alternative to the chemical treatments traditionally used in the industrial sector and complies with the new regulations in terms of chemical emissions into the environment. In a worldwide market for chemical biocides estimated to be worth EUR 21 bn(1), AMOEBA is today concentrating on the segment of industrial air-cooled towers (ACT), estimated to be worth EUR 1.7 bn(2). AMOEBA is continuing with the regulatory procedures necessary to obtain provisional MA for all European countries for the "Air Cooled Towers" application. Based in Lyon-Chassieu (France), AMOEBA is quoted on compartment C of the Euronext Paris stock exchange and joined the CAC® Small index on 21st September 2015. For more information: www.amoeba-biocide.com.
(1): Sources combined by Amoeba from water treatment agencies, Freedonia, Eurostat and MarketsandMarkets (2): Amoeba data combined from the following sources: DRIRE 2013, Eurostat, ARHIA 2013
Contacts:
Amoéba
Nathalie COMBROUSSE Marketing Communication Manager Tel. : +33 (0)4 81 09 18 15 [email protected]
Novochem Water Treatment
Robin Witte Director Tel.: +31 (0)30 602 15 33 [email protected]
Actifin Ghislaine GASPARETTO Financial Communication Tel. : +33 (0)1 56 88 11 11 [email protected]